학술논문
Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years
Document Type
Article
Author
Source
In: Allergy: European Journal of Allergy and Clinical Immunology . (Allergy: European Journal of Allergy and Clinical Immunology, 2024)
Subject
Language
English
ISSN
13989995
01054538
01054538